People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard mRNA vaccination.
Gainullin M, Federico L, Røkke Osen J, Chaban V, Kared H, Alirezaylavasani A, Lund-Johansen F, Wildendahl G, Jacobsen JA, Sarwar Anjum H, Stratford R, Tennøe S, Malone B, Clancy T, Vaage JT, Henriksen K, Wüsthoff L, Munthe LA.
Gainullin M, et al. Among authors: jacobsen ja.
Front Immunol. 2024 Jan 17;14:1235210. doi: 10.3389/fimmu.2023.1235210. eCollection 2023.
Front Immunol. 2024.
PMID: 38299149
Free PMC article.